Osteocalcin, vascular calcification, and atherosclerosis: a systematic review and meta-analysis

SA Millar, H Patel, SI Anderson, TJ England… - Frontiers in …, 2017 - frontiersin.org
Background Osteocalcin (OC) is an intriguing hormone, concomitantly being the most
abundant non-collagenous peptide found in the mineralized matrix of bone, and expanding …

The bone-vessel axis in chronic kidney disease: An update on biochemical players and its future role in laboratory medicine

L Pereira, JM Frazão - Clinica Chimica Acta, 2020 - Elsevier
Vascular wall calcification (VC) is highly prevalent in patients with chronic kidney disease
(CKD). In CKD, VC is more frequent and severe than in the general population and it is …

Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: a meta-analysis of observational studies

CDK Wungu, H Susilo, MY Alsagaff, BS Witarto… - Scientific Reports, 2024 - nature.com
This meta-analysis was conducted to clarify the role of klotho and fibroblast growth factor 23
(FGF-23) in human arterial remodeling across recent studies, in terms of arterial calcification …

Vascular calcification and the gut and blood microbiome in chronic kidney disease patients on peritoneal dialysis: a pilot study

A Merino-Ribas, R Araujo, L Pereira, J Campos… - Biomolecules, 2022 - mdpi.com
Vascular calcification (VC) is a frequent condition in chronic kidney disease (CKD) and a
well-established risk factor for the development of cardiovascular disease (CVD). Gut …

Elevated circulating osteoprotegerin levels in the plasma of hemodialyzed patients with severe artery calcification

M Krzanowski, K Krzanowska… - Therapeutic …, 2018 - Wiley Online Library
We studied the correlations between circulating osteoprotegerin (OPG) level and radial
artery calcification (RAC) assessed histologically and carotid artery intima‐media thickness …

Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients

O Ulutas, MC Taskapan, A Dogan, T Baysal… - … Urology and Nephrology, 2018 - Springer
Introduction Vascular calcification (VC) in hemodialysis (HD) patients is a sign of severe
cardiovascular disease and can predict cardiovascular outcomes. Fetuin-A and osteopontin …

Long-term effects of hypercalcemia in kidney transplant recipients with persistent hyperparathyroidism

JC Ramirez-Sandoval, L Marino… - Journal of …, 2023 - Springer
Background Hypercalcemia is highly prevalent in kidney transplant recipients with
hyperparathyroidism. However, its long-term impact on graft function is uncertain. Methods …

Comparison of cardiovascular outcomes by dialysis modality: a systematic review and meta-analysis

MR Lozier, AM Sanchez, JJ Lee… - Peritoneal Dialysis …, 2019 - journals.sagepub.com
Debates exist regarding the merit of starting one dialysis modality over the other for
improved cardiovascular outcomes. Five previously published prospective and retrospective …

Serum osteoprotegerin levels related with cardiovascular risk factors in chronic kidney disease

P Demir, F Erdenen, H Aral, T Emre… - Journal of Clinical …, 2016 - Wiley Online Library
Background To evaluate osteoprotegerin (OPG) levels in relation to cardiovascular (CV) risk
factors in patients with chronic kidney disease (CKD) on different regimens of renal …

Osteocalcin, osteopontin and RUNX2 expression in patients' leucocytes with arteriosclerosis

J Ukkat, C Hoang-Vu, B Trojanowicz, A Rebelo - Diseases, 2021 - mdpi.com
Introduction: Calcification is a highly relevant process in terms of development of
cardiovascular diseases, and its prevention may be the key to prevent disease progression …